Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nathaniel W. Mabe(Broad Institute), Min Huang(Stanford University), Guillermo Nicolás Dalton(Stanford University), Gabriela Alexe(Broad Institute), Daniel A. Schaefer(Boston Children's Hospital), Anna C. Geraghty(Stanford University), Amanda L. Robichaud(Boston Children's Hospital), Amy Saur Conway(Boston Children's Hospital), Delan Khalid(Boston Children's Hospital), Marius Marc-Daniel Mader(California Institute for Regenerative Medicine), Julia A. Belk(Stanford University), Kenneth N. Ross(Broad Institute), Michal Sheffer(Dana-Farber Cancer Institute), Miles H. Linde(Stanford University), Nghi Ly(Stanford University), Winnie Yao(Stanford University), Maria Caterina Rotiroti(Stanford University), Benjamin Smith(Stanford University), Marius Wernig(California Institute for Regenerative Medicine), Carolyn R. Bertozzi(Howard Hughes Medical Institute), Michelle Monje(Howard Hughes Medical Institute), Constantine S. Mitsiades(Dana-Farber Cancer Institute), Ravindra Majeti(Stanford University), Ansuman T. Satpathy(Gladstone Institutes), Kimberly Stegmaier(Broad Institute), Robbie G. Majzner(Parker Institute for Cancer Immunotherapy)
Cited by 108Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis